Filter
2286
Filtered Results: 2286
Text search:
bacterial
infections
Featured
Recommendations
322
New Publications
594
Language
Document type
No document type
1085
Guidelines
434
Studies & Reports
355
Manuals
147
Fact sheets
81
Strategic & Response Plan
72
Training Material
56
Situation Updates
14
Brochures
13
Infographics
11
Videos
9
Online Courses
6
Resource Platforms
3
Countries / Regions
India
151
South Africa
70
Global
67
Kenya
57
Tanzania
41
Ethiopia
40
Nigeria
38
Nepal
35
Africa
32
Bangladesh
32
Latin America and the Carribbean
31
Sierra Leone
30
Western and Central Europe
30
Uganda
30
Rwanda
26
Philippines
26
Ghana
24
Liberia
22
Malawi
20
Myanmar / Burma
19
Namibia
18
Zambia
18
Germany
14
South–East Asia Region
12
Colombia
11
Haiti
11
Venezuela
11
Argentina
11
Zimbabwe
10
Paraguay
10
Eswatini/ Swaziland
10
Eastern Europe
9
Russia
9
Indonesia
9
Ukraine
8
Lesotho
8
Eastern Europe and Central Asia
8
Mozambique
7
Burkina Faso
6
Cambodia
6
Asia
6
West and Central Africa
6
Bolivia
6
Brazil
6
Madagascar
6
Senegal
5
USA
5
Western Pacific Region
5
Botswana
5
Cameroon
4
Syria
4
Peru
4
Congo, Democratic Republic of
4
East and Southern Africa
4
North Macedonia
3
Tajikistan
3
Timor Leste/ East Timor
3
China
3
Chile
3
Guinea
3
Middle East and North Africa
3
Spain
3
Vietnam
3
Angola
3
South Sudan
3
Iraq
3
Ecuador
3
Pakistan
3
Thailand
2
Mexico
2
El Salvador
2
Serbia
2
Benin
2
Albania
2
Fiji
2
Afghanistan
2
Guinea-Bissau
2
Jordan
2
North America
2
Sri Lanka
2
Yemen
2
Honduras
2
Mali
2
Somalia
2
North Korea
1
Gambia
1
Kazakhstan
1
Iran
1
Laos
1
Kyrgyzstan
1
Congo-Brazzaville
1
Niger
1
Uzbekistan
1
Qatar
1
Armenia
1
Saudi Arabia
1
Gabon
1
Uruguay
1
Turkmenistan
1
Denmark
1
Belgium
1
France
1
Maldives
1
Mauritius
1
United Kingdom
1
Latvia
1
Southern Africa
1
Côte d’Ivoire / Ivory Coast
1
Lebanon
1
Papua New Guinea
1
Nicaragua
1
Egypt
1
Sudan
1
Georgia
1
Central African Republic
1
Libya
1
Bhutan
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
775
Clinical Guidelines
318
Women & Child Health
138
Key Resources
119
Public Health
91
Capacity Building
55
Pharmacy & Technologies
39
Toolboxes
AMR
349
TB
208
COVID-19
149
HIV
141
Rapid Response
109
NTDs
106
Planetary Health
90
Caregiver
81
Pharmacy
69
Cholera
44
Ebola
43
Refugee
40
Mental Health
30
Conflict
24
Natural Hazards
23
NCDs
22
Global Health Education
19
Specific Hazards
14
Disability
14
Zika
12
Polio
7
Social Ethics
1
Health Financing Toolbox
1
Buruli ulcer is a chronic, progressive skin disease caused by infection with Mycobacterium ulcerans. It is currently considered to be one of the neglected tropical diseases; less common than tuberculosis but more common than leprosy. The initial lesion is a painless subcutaneous nodule, usually less...
Human scabies is a parasitic infestation caused by Sarcoptes scabiei var hominis. The microscopic mite burrows into the skin and lays eggs, eventually triggering a host immune response that leads to intense itching and rash. Scabies infestation may be complicated by bacterial infection, leading to t...
Antimicrobial agents like antibiotics are essential to treat some human and animal diseases. Microbes, such as bacteria, can develop resistance to antimicrobials meaning that a drug such as an antibiotic is no longer effective in treating the infection. The development of resistance is caused by the...
Overuse and misuse of antibiotics in animals and humans is contributing to the rising threat of antibiotic resistance. Some types of bacteria that cause serious infections in humans have already developed resistance to most or all of the available treatments, and there are very...
Antimicrobial resistance (AMR) represents a major global threat across human, animal, plant food and environmental sectors, threatening the effective treatment of an ever-increasing range of infections caused by bacteria, parasites, viruses and fungi, resulting in prolonged illness and increased mor...
Antimicrobial resistance learning channel
recommended
Antimicrobial resistance (AMR) is one of the top 10 global public health threats facing humanity. AMR threatens the effective prevention and treatment of an ever-increasing range of infections caused by bacteria, parasites, viruses and fungi.
It occurs when microorganisms develop resistance to me...
Antimicrobials are used in veterinary medicine to treat infectious diseases in animals caused or complicated by microorganisms, mainly bacteria, or to prevent the development or spread of infection in healthy animals.
Mycetoma is a chronic disease usually of the foot but any part of the body can be affected. Infection is most probably acquired by traumatic inoculation of fungi or bacteria into the subcutaneous tissue. So far more than 70 different bacteria and fungi have been indicated as causative agents.
Of the 50 antibiotics in the pipeline, 32 target WHO priority pathogens but the majority have only limited benefits when compared to existing antibiotics. Two of these are active against the multi-drug resistant Gram-negative bacteria, which are spreading rapidly and require urgent solutions.
Gr...
Historically, the discovery of the sulfa drugs in the 1930s and the subsequent development of penicillin during World War II ushered in a new era in the treatment of infectious diseases. Infections that were common causes of death and disease in the pre-...
Policy Brief November 2021 Available in English, Spanish and Portuguese
The COVID-19 pandemic has fueled the ongoing antimicrobial resistance (AMR) global crisis due to the increase in the use of antibiotics to treat COVID-19 patients, disruptions to infection prevention and control practices in o...
Antimicrobials are medicines, including antibiotics, antivirals, antifungals, and antiparasitics, that are used to prevent and treat infections in humans, animals, and plants. Antimicrobial Resistance (AMR) arises when bacteria, viruses, fungi, and parasites no longer respond to these medicines, ren...
Emergence of antimicrobial resistance is a result of the use, overuse and misuse of antibiotics both in humans and animals. In Ethiopia, there are indications on the misuse of antibiotics by health care providers’, unskilled practitioners, and drug consumers. These coupled with rapid spread of res...
Antibiotics have been a critical public health tool since the discovery of Penicillin in 1928, saving the lives of millions of people around the world. In developing country like ours, where the burden of treatable disease is very high and access to health facilities and laboratories is difficult, a...
Pakistan Global Antibiotic Resistance Partnership (GARP) was formed in the wake of international and national efforts for AMR curtailment. A group of experts from microbiology, infectious diseases and veterinary medicine formed a core group at the organizational meet...
Over a period of two decades, under-5 mortality rate in Bangladesh has declined by 66% from 133 per 1000 live births in 1993-94 to 45 per 1000 live births in 2017-18. The country reached the MDG-4 goal in the reduction of child mortality on time. However, the comparison of neonatal and under-5 morta...
Buruli ulcer caused by Mycobacterium ulcerans is a neglected tropical disease characterized by extensive ulceration involving predominantly the upper and lower limbs of patients. The disease is common in rural tropical communities in West and Central Africa, where access to proper health care is lim...
In a retrospective review of hospital records of 40 human monkeypox cases from Nigeria, the majority developed fever and self-limiting vesiculopustular skin eruptions. Five deaths
were reported. Compared to human immunodeficiency virus (HIV)–negative cases, HIV type 1–coinfected cases had more ...
i. A person who is a contact of a probable or confirmed mpox case in the 21 days before the onset of signs or symptoms, and who presents with any of the following: acute onset of fever (>38.5°C), headache, myalgia (muscle pain/body aches), back pain, profound weakness or fatigue.
OR
ii. A per...
WHO today published the new edition of its Model Lists of Essential Medicines and Essential Medicines for Children, which include new treatments for various cancers, insulin analogues and new oral medicines for diabetes, new medicines to assist people who want to stop smoking, and new antimicrobials...
